A Dynamic Inflammatory Cytokine Network in the Human Ovarian Cancer Microenvironment

被引:177
作者
Kulbe, Hagen [1 ]
Chakravarty, Probir [2 ]
Leinster, D. Andrew [1 ]
Charles, Kellie A. [1 ]
Kwong, Joseph [1 ]
Thompson, Richard G. [1 ]
Coward, Jermaine I. [1 ]
Schioppa, Tiziana [1 ]
Robinson, Stephen C. [1 ]
Gallagher, William M. [3 ]
Galletta, Laura [5 ]
Salako, Michael A. [1 ]
Smyth, John F. [4 ]
Hagemann, Thorsten [1 ]
Brennan, Donal J. [3 ]
Bowtell, David D. [5 ]
Balkwill, Frances R. [1 ]
机构
[1] Queen Mary Univ London, Ctr Canc & Inflammat, Barts Canc Inst, London, England
[2] Bioinformat & Biostat Serv, Canc Res UK, London, England
[3] Univ Coll Dublin, UCD Conway Inst, UCD Sch Biomol & Biomed Sci, Dublin 2, Ireland
[4] Western Gen Hosp, Edinburgh Canc Res UK Ctr, Edinburgh EH4 2XU, Midlothian, Scotland
[5] Univ Melbourne, Dept Biochem & Mol Biol, Peter MacCallum Canc Inst, Melbourne, Vic, Australia
基金
英国医学研究理事会;
关键词
NECROSIS-FACTOR-ALPHA; EXPRESSION;
D O I
10.1158/0008-5472.CAN-11-2178
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Constitutive production of inflammatory cytokines is a characteristic of many human malignant cell lines; however, the in vitro and in vivo interdependence of these cytokines, and their significance to the human cancer microenvironment, are both poorly understood. Here, we describe for the first time how three key cytokine/chemokine mediators of cancer-related inflammation, TNF, CXCL12, and interleukin 6, are involved in an autocrine cytokine network, the "TNF network," in human ovarian cancer. We show that this network has paracrine actions on angiogenesis, infiltration of myeloid cells, and NOTCH signaling in both murine xenografts and human ovarian tumor biopsies. Neutralizing antibodies or siRNA to individual members of this TNF network reduced angiogenesis, myeloid cell infiltration, and experimental peritoneal ovarian tumor growth. The dependency of network genes on TNF was shown by their downregulation in tumor cells from patients with advanced ovarian cancer following the infusion of anti-TNF antibodies. Together, the findings define a network of inflammatory cytokine interactions that are crucial to tumor growth and validate this network as a key therapeutic target in ovarian cancer. Cancer Res; 72( 1); 66-75. (C) 2011 AACR.
引用
收藏
页码:66 / 75
页数:10
相关论文
共 23 条
[1]   Immune response in silico (IRIS): immune-specific genes identified from a compendium of microarray expression data [J].
Abbas, AR ;
Baldwin, D ;
Ma, Y ;
Ouyang, W ;
Gurney, A ;
Martin, F ;
Fong, S ;
Campagne, MV ;
Godowski, P ;
Williams, PM ;
Chan, AC ;
Clark, HF .
GENES AND IMMUNITY, 2005, 6 (04) :319-331
[2]   IL6-STAT3-HIF Signaling and Therapeutic Response to the Angiogenesis Inhibitor Sunitinib in Ovarian Clear Cell Cancer [J].
Anglesio, Michael S. ;
George, Joshy ;
Kulbe, Hagen ;
Friedlander, Michael ;
Rischin, Danny ;
Lemech, Charlotte ;
Power, Jeremy ;
Coward, Jermaine ;
Cowin, Prue A. ;
House, Colin M. ;
Chakravarty, Probir ;
Gorringe, Kylie L. ;
Campbell, Ian G. ;
Okamoto, Aikou ;
Birrer, Michael J. ;
Huntsman, David G. ;
de Fazio, Anna ;
Kalloger, Steve E. ;
Balkwill, Frances ;
Gilks, C. Blake ;
Bowtell, David D. .
CLINICAL CANCER RESEARCH, 2011, 17 (08) :2538-2548
[3]  
[Anonymous], R LANG ENV STAT COMP
[4]   Integrated genomic analyses of ovarian carcinoma [J].
Bell, D. ;
Berchuck, A. ;
Birrer, M. ;
Chien, J. ;
Cramer, D. W. ;
Dao, F. ;
Dhir, R. ;
DiSaia, P. ;
Gabra, H. ;
Glenn, P. ;
Godwin, A. K. ;
Gross, J. ;
Hartmann, L. ;
Huang, M. ;
Huntsman, D. G. ;
Iacocca, M. ;
Imielinski, M. ;
Kalloger, S. ;
Karlan, B. Y. ;
Levine, D. A. ;
Mills, G. B. ;
Morrison, C. ;
Mutch, D. ;
Olvera, N. ;
Orsulic, S. ;
Park, K. ;
Petrelli, N. ;
Rabeno, B. ;
Rader, J. S. ;
Sikic, B. I. ;
Smith-McCune, K. ;
Sood, A. K. ;
Bowtell, D. ;
Penny, R. ;
Testa, J. R. ;
Chang, K. ;
Dinh, H. H. ;
Drummond, J. A. ;
Fowler, G. ;
Gunaratne, P. ;
Hawes, A. C. ;
Kovar, C. L. ;
Lewis, L. R. ;
Morgan, M. B. ;
Newsham, I. F. ;
Santibanez, J. ;
Reid, J. G. ;
Trevino, L. R. ;
Wu, Y. -Q. ;
Wang, M. .
NATURE, 2011, 474 (7353) :609-615
[5]   CONTROLLING THE FALSE DISCOVERY RATE - A PRACTICAL AND POWERFUL APPROACH TO MULTIPLE TESTING [J].
BENJAMINI, Y ;
HOCHBERG, Y .
JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES B-STATISTICAL METHODOLOGY, 1995, 57 (01) :289-300
[6]   The genesis and evolution of high-grade serous ovarian cancer [J].
Bowtell, David D. L. .
NATURE REVIEWS CANCER, 2010, 10 (11) :803-808
[7]   Tumour-specific HMG-CoAR is an independent predictor of recurrence free survival in epithelial ovarian cancer [J].
Brennan, Donal J. ;
Brandstedt, Jenny ;
Rexhepaj, Elton ;
Foley, Michael ;
Ponten, Fredrik ;
Uhlen, Mathias ;
Gallagher, William M. ;
O'Connor, Darran P. ;
O'Herlihy, Colm ;
Jirstrom, Karin .
BMC CANCER, 2010, 10
[8]   A system for stable expression of short interfering RNAs in mammalian cells [J].
Brummelkamp, TR ;
Bernards, R ;
Agami, R .
SCIENCE, 2002, 296 (5567) :550-553
[9]   TheEGF receptor family: spearheading a merger of signaling and therapeutics [J].
Bublil, Erez M. ;
Yarden, Yosef .
CURRENT OPINION IN CELL BIOLOGY, 2007, 19 (02) :124-134
[10]   The tumor-promoting actions of TNF-α involve TNFR1 and IL-17 in ovarian cancer in mice and humans [J].
Charles, Kellie A. ;
Kulbe, Hagen ;
Soper, Robin ;
Escorcio-Correia, Monica ;
Lawrence, Toby ;
Schultheis, Anne ;
Chakravarty, Probir ;
Thompson, Richard G. ;
Kollias, George ;
Smyth, John F. ;
Balkwill, Frances R. ;
Hagemann, Thorsten .
JOURNAL OF CLINICAL INVESTIGATION, 2009, 119 (10) :3011-3023